Melflufen and dexamethasone (dex) plus bortezomib (BTZ) or daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) (OP-104)
Por:
Pour, L, Efebera, Y, Granell, M, Hajek, R, Oriol, A, Delaunay, J, Le Du, K, Eveillard, JR, Karlin, L, Maisnar, V, Martinez-Lopez, J, Mateos, MV, Moreb, J, Ribrag, V, Richardson, PG, Straub, J, Byrne, C, Jacques, C, Zubair, H and Ocio, E
Publicada:
1 jul 2019
Resumen:
Filiaciones:
Pour, L:
Fakultni Nemocnice Brno, Brno, Czech Republic
Efebera, Y:
Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
Granell, M:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Hajek, R:
Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Delaunay, J:
Hop Prive Confluent, Nantes, France
Le Du, K:
Ctr Jean Bernard, Dept Hematol, Clin Victor Hugo, Le Mans, France
Eveillard, JR:
Hop Morvan, Brest, France
Karlin, L:
Univ Claude Bernard Lyon 1, Ctr Hosp Lyon Sud, Dept Hematol, Pierre Benite, France
Maisnar, V:
FN & LF UK Hradec Kralove, Dept Med Hematol 4, Hradec Kralove, Czech Republic
Martinez-Lopez, J:
Hosp Univ 12 Octubre, Madrid, Spain
Mateos, MV:
Hosp Clin Univ Salamanca, Salamanca, Spain
Moreb, J:
Univ Florida, Hlth Canc Ctr, Gainesville, FL USA
Ribrag, V:
Univ Paris Saclay, Gustave Roussy, DITEP, Villejuif, France
Richardson, PG:
Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
Straub, J:
Vseobecna Fakultni Nemocnice, Prague, Czech Republic
Byrne, C:
Oncopeptides AB, Stockholm, Sweden
Jacques, C:
Oncopeptides AB, Stockholm, Sweden
Zubair, H:
Oncopeptides AB, Stockholm, Sweden
Ocio, E:
Hosp Clin Univ Salamanca, Salamanca, Spain
|